Clinical Trial Update: Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of an injectable fluocinolone acetonide intravitreal insert for uveitis has been terminated, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermediate Uveitis
• Posterior Uveitis
• Uveitis

Drugs mentioned

• Fluocinolone acetonide intravitreal insert (fluocinolone acetonide intravitreal insert)

Snippet

Sponsor: EyePoint Pharmaceuticals, Inc. | Conditions: Uveitis, Uveitis, Posterior | Phase 3 | Status: TERMINATED | Results posted: 2024-12-19